A senior at a Utah high school received a scholarship this month based on her idea for an automated CPR assistance device.

The FDA has granted Breakthrough Device status to BioVentrix, Inc.’s Revivent TC Transcatheter Ventricular Enhancement System, a proactive approach to treating MI-induced heart failure.

A new structural heart disease initiative from the American Heart Association and Edwards Lifesciences will aim to raise patient awareness of valve diseases while enriching patient education and engagement.

Nearly one-third of insured adults with diagnosed hypertension were nonadherent to their antihypertensive medications in 2015, according to a report published Nov. 4 in Hypertension.

A novel pacemaker designed to mimic a patient’s organic breath increased blood flow to the heart in a study of individuals with heart failure, according to research published in the journal Thorax.

Patients with heart failure and reduced ejection fraction are well served by treatment with the glucose-lowering drug dapagliflozin, as it warded off death and hospitalization while also improving quality of life when added to standard care regimens in a major trial.

Apple has opted to remove all vaping-related apps from its App Store in the midst of an e-cigarette epidemic that’s fueled more than 2,000 cases of vaping-related lung injury and at least 42 fatalities.

Results of the late-breaking COLCOT trial, which explored the efficacy of low-dose colchicine in reducing CV risk in heart attack patients, were a highlight of the American Heart Association’s 2019 Scientific Sessions this month in Philadelphia.